Go Back
SINOVAC Vaccine
The study, sponsored by the Butantan Institute, a partner of SINOVAC,
will be carried out in 12 research centres in six states of Brazil, and plans to recruit nearly 9000 volunteers,
who will start joining the group this month after receiving ethical approval from each research center.
This clinical study will further validate the safety and effectiveness of the new inactivated crown vaccine
KerrifoTM in Brazil, which is a key study to support the licensing of the vaccine.
will be carried out in 12 research centres in six states of Brazil, and plans to recruit nearly 9000 volunteers,
who will start joining the group this month after receiving ethical approval from each research center.
This clinical study will further validate the safety and effectiveness of the new inactivated crown vaccine
KerrifoTM in Brazil, which is a key study to support the licensing of the vaccine.
More Details
https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations